Welcome to Paid Research Studies




  • Condition:   Parkinson Disease
    Intervention:   Drug: sargramostim
    Sponsor:   University of Nebraska
    Recruiting

  • Condition:   Metastatic Pancreatic Cancer
    Interventions:   Drug: Gemcitabine;   Drug: Nab-paclitaxel;   Drug: Aldoxorubicin HCl;   Biological: ALT-803;   Biological: ETBX-011;   Biological: ETBX-021;   Biological: ETBX-051;   Biological: ETBX-061;   Biological: GI-4000;   Biological: GI-6207;   Biological: GI-6301;   Biological: haNK;   Drug: Avelumab;   Drug: Bevacizumab;   Drug: Capecitabine;   Drug: Cyclophosphamide;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: Oxaliplatin
    Sponsor:   NantKwest, Inc.
    Not yet recruiting